國立虎尾科技大學 |

Practical Pharmacology for Alzheimer’s Disease

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Practical Pharmacology for Alzheimer’s Disease/ by Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson.
作者:	Kudo, Takashi.
其他作者:	Davis, Kenneth L.
面頁冊數:	VIII, 141 p. 27 illus., 18 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Psychopharmacology. -
電子資源:	https://doi.org/10.1007/978-3-319-26206-2
ISBN:	9783319262062

Practical Pharmacology for Alzheimer’s Disease
Kudo, Takashi.

Practical Pharmacology for Alzheimer’s Disease[electronic resource] /by Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson. - 1st ed. 2016. - VIII, 141 p. 27 illus., 18 illus. in color.online resource.

Basic theory of pharmacology for Alzheimer’s disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

ISBN: 9783319262062

Standard No.: 10.1007/978-3-319-26206-2doiSubjects--Topical Terms:

644799
Psychopharmacology.

LC Class. No.: RM315-334

Dewey Class. No.: 615.78

Practical Pharmacology for Alzheimer’s Disease
LDR:02556nam a22003975i 4500 001 982810
003 DE-He213
005 20200704040748.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319262062 $9 978-3-319-26206-2
024 7 $a 10.1007/978-3-319-26206-2 $2 doi
035 $a 978-3-319-26206-2
050 4 $a RM315-334
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
072 7 $a MKGW $2 thema
082 0 4 $a 615.78 $2 23
100 1 $a Kudo, Takashi. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1106211
245 1 0 $a Practical Pharmacology for Alzheimer’s Disease $h [electronic resource] / $c by Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a VIII, 141 p. 27 illus., 18 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Basic theory of pharmacology for Alzheimer’s disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
520 $a The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
650 0 $a Psychopharmacology. $3 644799
650 0 $a Neurology . $3 1253459
650 0 $a Pharmacotherapy. $3 973587
650 2 4 $a Neurology. $3 593894
700 1 $a Davis, Kenneth L. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1274798
700 1 $a Blesa Gonzalez, Rafael. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1274799
700 1 $a Wilkinson, David George. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1274800
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319262048
776 0 8 $i Printed edition: $z 9783319262055
776 0 8 $i Printed edition: $z 9783319799063
856 4 0 $u https://doi.org/10.1007/978-3-319-26206-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)